Molecular biology tools company Zymo Research said on Tuesday that it plans to introduce its ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma and serum, in partnership with Tecan.
The DreamPrep NAP workstation, which features Zymo Research's Quick-DNA/RNA Viral MagBead Kit, provides pre-loaded scripts and optimized for viral RNA extraction, which are currently being validated for COVID-19 assays by high complexity testing labs.
Zymo's DreamPrep NAP workstation workflows require time-consuming scripting, configuration and optimization for the nucleic acid extraction to function properly, which can dramatically decrease lab scalability in this critical time.
In addition, the preprogrammed, preconfigured, load-and-go system is optimized for high-throughput viral RNA extraction. The workstation features a user-friendly interface and guided setup to streamline implementation, concluded the partnership.
Akeso's ligufalimab (CD47 mAb) granted FDA Orphan Drug Designation for AML
Forte Biosciences highlights positive FB102 data in celiac disease at Tampere Symposium
SureSpace Launches in Dubai to Tackle Doomscrolling and Redefine Social Networking
Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation
Biophytis secures Brazilian funding and partnerships for obesity Phase 2 trial
Phrontline Biopharma doses first patient in TJ101 Phase 1 clinical trial
Gene Solutions' mitochondrial therapy platform targeting neurological diseases secures patent
Zhimeng Biopharma's investigational drug gains Phase 2 epilepsy clinical trial approval in China
Avidity Biosciences prices upsized common stock public offering
Sanofi's SAR402663 granted FDA fast track designation for wet AMD
Endo to share PFI and PFA data at American Orthopaedic Foot & Ankle Society Annual Meeting
Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes
Sobi's Biologics License Application for NASP in uncontrolled gout accepted by FDA